Answer
Serious hypersensitivity reactions reported with erenumab after marketing include rash, angioedema and anaphylactic reactions, occurring within minutes or, in some cases, more than one week after treatment.
Sources for this answer
- Aimovig solution for injection in pre filled penNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 12Document updated
Sources checked